Alprostadil is an approved medicine with a defined safety profile. This page summarises how its potential side effects are discussed and does not constitute medical advice; use should be supervised by a clinician.
Overview
Because alprostadil works by dilating blood vessels, its side effects follow logically from that action and from where it is administered. As an approved medicine it has a characterized safety profile, but several effects are notable enough to warrant attention and, in one case, urgent care.
Local site effects
A common category of effect relates to the site of administration:
- Pain or discomfort in the treated area.
- Injection-site or application-site reactions.
- Local sensations linked to increased blood flow.
These are among the more frequently discussed effects in the erectile-dysfunction setting.
Prolonged erection (priapism)
A specific and important risk in the erectile-dysfunction context is priapism, a prolonged and often painful erection. This is a recognized effect of the drug's action on erectile blood flow and is considered a medical emergency requiring prompt attention, because unresolved priapism can cause lasting harm.
Systemic vasodilatory effects
When alprostadil reaches the broader circulation, its vasodilation can produce systemic effects:
- Lowered blood pressure.
- Flushing or related sensations.
- In the newborn setting, recognized effects such as apnea that are actively monitored.
Context and caveats
Alprostadil's risks are well enough understood that they shape how and where it is used, including hospital monitoring in newborns and clear guidance about priapism in erectile-dysfunction use. Its safety depends on staying within approved indications and clinical supervision. Combining it with other vasodilators can amplify blood-pressure effects, which is one reason clinician involvement matters.